response before reaching any therapeutic conclusions. The most serious risk to the patient is either that the doctor will try new drugs or that the patient will insist on a new non-operative treatment. There are two other risks: firstly, the patient may not be checked for the complications of prostatic obstruction such as bladder decompensation, diverticula, stones, hydronephrosis, or even uraemia; and, secondly, without a tissue diagnosis automatically obtained at the time of an operative prostatectomy focal carcinoma in up to a fifth of patients may be missed.
The cost of managing patients with benign prostatic hyperplasia is large-yet neither basic research into this disease nor the economic implications has attracted much interest, especially in Britain. In the United States Glynn et al reported a 29% probability of a 40 year old man having a prostatectomy. 26 The indications for prostatectomy for symptoms are imprecise; three quarters of men over 50 will have symptoms thought to be related to an enlarged prostate -yet there is much debate whether these symptoms are caused by bladder outflow obstruction.27 There is also a debate over when these symptoms and signs indicate the need for prostatectomy.2829 So it is not surprising that there should be variations in the rates of prostatectomy both regionally and nationally, but some of the larger discrepancies require further study. As populations age and patient expectations increase the prospect of controlling symptoms in some of these patients should attract more interest, especially if it eases the operative workload.
Treating patients with asthma who are dependent on systemic steroids Thefirst step is to give inhaled steroids Despite advances in treating asthma some patients still need continuous treatment with systemic corticosteroids. Such treatment has many side effects, including hyperglycaemia, hypertension, fluid retention, peptic ulceration, Cushing's syndrome, myopathy, increased susceptibility to infections, and behavioural disturbances. Osteoporosis seems to be particularly common, and a retrospective assessment of 128 patients aged 40 or above with asthma who are dependent on steroids noted vertebral or rib fractures in 11%, but there were no fractures in 54 patients treated intermittently with systemic steroids.' The high incidence of side effects is often well known to patients, who may take the treatment irregularly or refuse it altogether. Measures to reduce the dose of steroids deserve close attention.
Any patient who requires maintenance treatment with oral corticosteroids should also have inhaled corticosteroids in order to minimise the systemic dose. But inhaled steroids are often not given.2 A dose of 800 [tg of inhaled beclomethasone allows for an appreciable reduction of the required dose of systemic steroids.34 Some asthmatic patients, however, still require oral treatment, and for them further treatment that spared the use of steroids would be valuable.
Alternatives to systemic steroids are usually drugs, but removing precipitating environmental factors and treating aggravating psychological causes may help. Various drugs have been proposed. Troleandomycin, a macrolide antibiotic, was described over 30 years ago because it prolonged the half life of methylprednisolone by slowing its elimination. But with doses of 1000 mg daily most patients had steroid related side effects,5 and half had abnormalities in liver function. 6 More recently daily doses of 250 mg together with a rapid tapering of the dose of systemic steroids led to a two thirds reduction in overall steroid requirement; most patients were maintained on alternate day treatment and had no abnormalities in liver function.7 It is not clear whether troleandomycin has any other mechanism of action apart from slowing the elimination of methylprednisolone.
Parenteral gold has been given extensively for. asthma in Japan for the past 15 years. It seems to exert an immunomodulatory effect on the IgE dependent system without compromising cell mediated immunity. Recently an oral gold preparation was given to asthmatic patients dependent on steroids in an open trial, and a reduction of a third in cumulative dosage of steroids was achieved. There was a correlation between the reduction in dose and responsiveness to methacholine.8 Side effects-particularly proteinuria, stomatitis, and diarrhoea-could prove troublesome.
Azathioprine in daily doses of 2 mg/kg body weight and 5 mg/kg has been studied in asthmatic patients dependent on steroids in short double blind crossover studies with no obvious benefit.9 And leucopenia, dyspepsia, and a threefold increase in the incidence of non-Hodgkin's lymphoma are all known complications.
Low dose methotrexate (15 mg a week) was recently shown in a double blind crossover trial to reduce the requirement for systemic prednisolone by just over a third.'0 This needs confirming in a longer trial with more patients. Methotrexate has an anti-inflammatory action in addition to suppressing the primary immune response. Unlike azathioprine, it does
Unfortunately the trials we have mentioned are difficult to assess as inhaled steroids were either not given at all or given in uncertain amounts. There is clearly a need for an alternative treatment to systemic steroids in this group of patients. The treatment should be less toxic and at least as efficacious. In any trials of new drugs optimal doses of bronchodilators and inhaled steroids should be rigidly defined, and it is important to know whether the drug is effective in its own right or only as a "steroid sparing agent." 
Serious gaps in response to Griffiths
Local authorities given the lead: no provision for central direction
The vacuum created by the government's 16 month silence over the Griffiths report on community care was naturally filled with speculation, rumour, and gossip. Policy discussions lurched back and forth over old ground about which agency should take lead responsibility. Finally, the government has taken a courageous decision, which would have been unthinkable a year ago, to implement the most controversial of Griffiths's proposals and give local authority social services departments the lead responsibility for community care. Their job will be to assess the needs in their localities, set local priorities and service objectives, and arrange the care required by designing, organising, and purchasing it. To allow them to do this effectively social security benefits and existing funds for community care are to be channelled through the single gateway of local authority social services. This money will also be available to support patients at home. If this is adequately funded it will be the first major government initiative to foster care at home, usually the first choice of patients and their families. It will also address the government's concern over the escalating social security bill for residential care, which has now risen to £1 billion annually.
There are, however, serious gaps in the government's response, which need to be addressed in detail in the white paper promised for the autumn. Griffiths wanted much more decisive central government action to set clear objectives and priorities. He wanted the allocation of resources to social services to be linked with developing nationally agreed plans, and he proposed that there should be tight financial control to ensure that local authorities could not siphon off funds allocated for community care to other more attractive causes. A minister for community care was proposed. There was no such central direction contained in the health minister's speech to parliament last week, and as yet no mechanisms have been devised by which the government can ensure that local planning and implementation are consistent with national priorities. The Social Services Inspectorate has no teeth, and its recommendations are often ignored. If the inspectorate is to monitor these plans then it needs wider powers.
A crucial part of Griffiths's report was the support of the concept of "care management" by which budget holding managers are given responsibility to ensure that an appropriate "package" of services is delivered to a group of clients. Without some fundamental reorganisation of the management of social services and a cultural and attitudinal change in local authorities, shifting money from the social security purse into social services will have little impact on consumers and their families on the receiving end of community care.
The proposals have the potential for righting the current gross geographical imbalance of services-but only if resources available to authorities match the local costs of domiciliary and residential care. At present prosperous areas with a plentiful supply of houses for conversion for residential care are paradoxically often the cheapest areas in which to provide care. Social security benefits pour into suburban and rural retirement areas leaving inner city dwellers unable to pay for the cost of a local residential or nursing home place within benefit levels. The allocation of resources to authorities must be linked not only to social need in terms of the prevalence of disability and the demographic pattern of handicap and mental illness but also to the local cost of delivering that care. Current patterns of allocating social security benefit are distorted by local availability of residential care. The revenue funding of the white paper Working for Patients recognises the fundamental principle that geographical accident should not disadvantage patients from access to good local care. The same principle must be embodied in the white paper on community care.
The impact on the health service may be surprisingly slight. The response falls back on "the discredited refuge of exhortation to joint planning" between health and social services. Griffiths's nice turn of phrase warned the government against doing this, emphasising that there must be incentives to both authorities to engage in such activity. There is no such incentive mentioned in the response. I see no incentive either for social services to take on the responsibility for the care of patients in hospitals who no longer need the medical care provided in short stay wards but require extensive domiciliary support or residential care. Between 1986 and 1989, 15% of all the short stay hospital beds in my own health district were occupied by disabled people who stayed over 90 days and who were waiting for a residential place to be found. The quality of life for these people marooned on a short stay ward is poor, and it is a waste of short stay beds. If the government is serious about community care it must not neglect those patients who are trapped down an NHS cul de sac.
There is no mention in the government's response of releasing resources from the health service's existing provision for long stay care and transferring this resource to social services. Unless this is done we shall continue to have parallel services developing in the health service and local authorities,
